Sangeeta Bhargava

Title: Sangeeta Bhargava: Innovator in Immunogenic Compositions

Introduction

Sangeeta Bhargava is a notable inventor based in Potomac, MD (US). She has made significant contributions to the field of immunology through her innovative research and patents. Her work focuses on developing immunogenic compositions that can enhance the immune response against various viruses.

Latest Patents

Sangeeta Bhargava holds 1 patent titled "Fusogenic, self-propagating blebs as immunogenic compositions." This patent describes a method for producing self-propagating, fusogenic blebs from cells infected with Venezuelan Equine Encephalitis virus replicon particles (VRP). The unique properties of these blebs arise from the expression of heterologous genes encoding viral fusion proteins. These blebs can be harvested from the supernatants of cells exhibiting severe cytopathic effects and are utilized to create immunogenic compositions aimed at immunizing mammals against paramyxoviruses, including parainfluenza virus type 3.

Career Highlights

Sangeeta Bhargava is currently associated with Wyeth Holdings Corporation, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of viral immunology and developing potential therapeutic solutions.

Collaborations

Throughout her career, Sangeeta has collaborated with esteemed colleagues such as Gerald R Kovacs and Xiaoyan Mo. These collaborations have further enriched her research and contributed to the success of her projects.

Conclusion

Sangeeta Bhargava's innovative work in the field of immunogenic compositions showcases her dedication to advancing medical science. Her contributions are paving the way for new methods of immunization against viral infections.